Terms & Conditions | Privacy Policy | Cookie Policy | Disclaimer | © Meticulous Business Plan 2026
Powered by MappedSkills Marketing
₹59,000.00
Build an ORS Powder & Liquid-Oral Rehydration Salts Manufacturing line with a bank-ready DPR or fund-ready Business Plan—market & pricing, material routes, process/ops design, compliance/claims guidance, and 5-year financials. Delivery: 12–15 working days.
Oral Rehydration Salts (ORS) manufacturing refers to the production of scientifically formulated electrolyte solutions used to prevent and treat dehydration caused by diarrhea, vomiting, heat stress, and fluid loss. ORS is a critical healthcare and lifesaving product recommended by the World Health Organization (WHO) and UNICEF, especially for infants, children, adults, and geriatric populations. ORS manufacturing plays a vital role in public health systems, emergency care, and primary healthcare delivery.
ORS products are formulated using a precise combination of glucose, sodium chloride, potassium chloride, and trisodium citrate or sodium bicarbonate, designed to enhance intestinal absorption of fluids and electrolytes. ORS is available in both powder form (to be dissolved in water) and ready-to-drink liquid formulations, ensuring flexibility in administration across hospitals, clinics, pharmacies, and homecare settings.
ORS products can be broadly classified based on formulation and presentation. By product type, the market includes ORS powder sachets and liquid ORS solutions. By formulation, it includes WHO-recommended low-osmolarity ORS, flavored ORS, zinc-fortified ORS, pediatric ORS, and adult ORS formulations. By end use, ORS is utilized in hospitals and clinics, government health programs, pharmacies, emergency relief operations, sports hydration, and household consumption.
The ORS manufacturing process involves raw material weighing, blending of pharmaceutical-grade ingredients, granulation (if required), drying, sieving, and sachet filling for powder ORS. Liquid ORS manufacturing includes water purification, ingredient dissolution, mixing, filtration, sterilization or pasteurization, and bottling under hygienic and controlled conditions. Modern ORS manufacturing units use automated blending systems, sachet packing machines, liquid filling lines, and quality control laboratories to ensure batch-to-batch consistency and regulatory compliance.
ORS is widely used in the treatment of acute diarrhea, cholera, gastroenteritis, heat exhaustion, dehydration due to illness, and post-operative fluid loss. It is also increasingly adopted as a hydration solution for athletes, outdoor workers, and individuals exposed to high temperatures. Growing awareness of dehydration-related health risks and increasing government focus on preventive healthcare have significantly increased ORS consumption worldwide.
India holds a strong position in ORS manufacturing due to a large domestic healthcare market, strong pharmaceutical manufacturing base, government health initiatives, and export demand from developing and emerging economies. The presence of established pharma infrastructure and low-cost manufacturing further enhances India’s competitiveness in the global ORS market.
Growth Drivers
Oral Rehydration Salts (ORS) manufacturing refers to the production of scientifically formulated electrolyte solutions used to prevent and treat dehydration caused by diarrhea, vomiting, heat stress, and fluid loss. ORS is a critical healthcare and lifesaving product recommended by the World Health Organization (WHO) and UNICEF, especially for infants, children, adults, and geriatric populations. ORS manufacturing plays a vital role in public health systems, emergency care, and primary healthcare delivery.
ORS products are formulated using a precise combination of glucose, sodium chloride, potassium chloride, and trisodium citrate or sodium bicarbonate, designed to enhance intestinal absorption of fluids and electrolytes. ORS is available in both powder form (to be dissolved in water) and ready-to-drink liquid formulations, ensuring flexibility in administration across hospitals, clinics, pharmacies, and homecare settings.
ORS products can be broadly classified based on formulation and presentation. By product type, the market includes ORS powder sachets and liquid ORS solutions. By formulation, it includes WHO-recommended low-osmolarity ORS, flavored ORS, zinc-fortified ORS, pediatric ORS, and adult ORS formulations. By end use, ORS is utilized in hospitals and clinics, government health programs, pharmacies, emergency relief operations, sports hydration, and household consumption.
The ORS manufacturing process involves raw material weighing, blending of pharmaceutical-grade ingredients, granulation (if required), drying, sieving, and sachet filling for powder ORS. Liquid ORS manufacturing includes water purification, ingredient dissolution, mixing, filtration, sterilization or pasteurization, and bottling under hygienic and controlled conditions. Modern ORS manufacturing units use automated blending systems, sachet packing machines, liquid filling lines, and quality control laboratories to ensure batch-to-batch consistency and regulatory compliance.
ORS is widely used in the treatment of acute diarrhea, cholera, gastroenteritis, heat exhaustion, dehydration due to illness, and post-operative fluid loss. It is also increasingly adopted as a hydration solution for athletes, outdoor workers, and individuals exposed to high temperatures. Growing awareness of dehydration-related health risks and increasing government focus on preventive healthcare have significantly increased ORS consumption worldwide.
India holds a strong position in ORS manufacturing due to a large domestic healthcare market, strong pharmaceutical manufacturing base, government health initiatives, and export demand from developing and emerging economies. The presence of established pharma infrastructure and low-cost manufacturing further enhances India’s competitiveness in the global ORS market.
Growth Drivers
Market Size & Outlook
Global Market:
The project reports provide detailed insights into:
These reports offer a comprehensive feasibility analysis along with suitable business models and structured implementation plans.
DPR: ₹59,000 — Delivery: 12–15 working days
Add-ons: Customization ₹3,500 · Expert Call ₹2,500 · Editable Files ₹4,500 · Extra Revisions ₹1,500 (first revision free)
Delivery Mode: Secure email/download link. Support: Email for clarifications.
Is ORS manufacturing a profitable business?
Yes. ORS is an essential healthcare product with stable, recurring demand across domestic and international markets.
What are the major end-use segments?
Hospitals, clinics, pharmacies, government health programs, NGOs, sports hydration, and retail consumers.
Are bank loans and funding options available?
Yes. The project reports are structured to support MSME loans, term loans, and institutional funding.
What approvals are required?
Drug manufacturing license, WHO-GMP compliance, CDSCO approvals, pollution control clearance, and packaging & labeling compliance are required.
